Walleye Capital LLC Prothena Corp Public LTD CO Call Options Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$19.54 - $26.15 $115,286 - $154,285
-5,900 Reduced 88.06%
800 $16,000
Q1 2024

May 15, 2024
BUY
$24.75 - $40.66 $165,825 - $272,422
6,700 New
6,700 $165,000
Q2 2023

Aug 14, 2023
BUY
$48.26 - $78.59 $139,954 - $227,911
2,900 New
2,900 $198,000
Q2 2019

Aug 14, 2019
SELL
$8.85 - $12.49 $46,905 - $66,197
-5,300 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$10.32 - $14.49 $54,696 - $76,797
5,300 New
5,300 $64,000

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $685M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email